Taldefgrobep Alfa in Adults With Overweight and Obesity
Clinical trial NCT07281495 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07281495
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-24
- Primary completion
- 2026-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.